Correlation Between Enzymatica Publ and AlzeCure Pharma
Can any of the company-specific risk be diversified away by investing in both Enzymatica Publ and AlzeCure Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enzymatica Publ and AlzeCure Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enzymatica publ AB and AlzeCure Pharma, you can compare the effects of market volatilities on Enzymatica Publ and AlzeCure Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enzymatica Publ with a short position of AlzeCure Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enzymatica Publ and AlzeCure Pharma.
Diversification Opportunities for Enzymatica Publ and AlzeCure Pharma
-0.51 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Enzymatica and AlzeCure is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Enzymatica publ AB and AlzeCure Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AlzeCure Pharma and Enzymatica Publ is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enzymatica publ AB are associated (or correlated) with AlzeCure Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AlzeCure Pharma has no effect on the direction of Enzymatica Publ i.e., Enzymatica Publ and AlzeCure Pharma go up and down completely randomly.
Pair Corralation between Enzymatica Publ and AlzeCure Pharma
Assuming the 90 days trading horizon Enzymatica Publ is expected to generate 11.26 times less return on investment than AlzeCure Pharma. But when comparing it to its historical volatility, Enzymatica publ AB is 2.74 times less risky than AlzeCure Pharma. It trades about 0.03 of its potential returns per unit of risk. AlzeCure Pharma is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 151.00 in AlzeCure Pharma on November 27, 2024 and sell it today you would earn a total of 22.00 from holding AlzeCure Pharma or generate 14.57% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enzymatica publ AB vs. AlzeCure Pharma
Performance |
| Timeline |
| Enzymatica publ AB |
| AlzeCure Pharma |
Enzymatica Publ and AlzeCure Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enzymatica Publ and AlzeCure Pharma
The main advantage of trading using opposite Enzymatica Publ and AlzeCure Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enzymatica Publ position performs unexpectedly, AlzeCure Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AlzeCure Pharma will offset losses from the drop in AlzeCure Pharma's long position.| Enzymatica Publ vs. Oncopeptides AB | Enzymatica Publ vs. Diamyd Medical AB | Enzymatica Publ vs. Kancera AB | Enzymatica Publ vs. Bonesupport Holding AB |
| AlzeCure Pharma vs. SaveLend Group AB | AlzeCure Pharma vs. Upsales Technology AB | AlzeCure Pharma vs. Viaplay Group AB | AlzeCure Pharma vs. Online Brands Nordic |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |